Omnipod Logo Pharmacist image



Dear Pharamacist,

Omnipod Dash® Insulin Managemenet System is the only tubeless full-featured insulin pump in the U.S. that is widely available through the pharmacy chanel and that simplifies diabetes care for people living with type 1 and insulin-requiring type 2 diabetes.1

Omnipod Dash® Insulin Management System consists of 2 primary parts

Omnipod DASH Insulin Management System
Pad shown without the necessary adhesive.

The PDM
The Personal Diabetes Manager (PDM) is a handheld, touchscreen device that controls and monitors the Pod's operations.



The Tubeless Pod
The waterproof* Pod is small, lightweight, and can provide up to 3 days insulin delivery.**

Omnipod Dash® System benefits

Simplifies insulin delivery2

Shows how one pod equals 14 injections
  • The Pod provides continuous insulin delivery of rapid-acting insulin*** - for up to 72 hours - no more multiple daily injections (1 injection with Pod vs 14 injections on Multiple Daily Injections regimen).3
  • No need for patient to ever see or touch the insertion needle with auto-cannula feature.

Simplifies getting started4

  • Omnipod DASH® System is covered by most plans, including commercial, Medicaid, and Medicare Part D, and available nationwide through retail pharmacies.5
  • Our Clinical Specialists will train and support you and your patients on how simple it is to start and use Omnipod DASH® System.
  • 3 simple steps to start:

    • fill the Pod with insulin
    • place on an approved location on the body
    • start the System up.

Simplifies diabetes management6

  • Mobile apps available to expand care team with remote access to patient data.

Morever

  • The majority of HCPs believe that the Omnipod DASH® System improves adherence to pump therapy and Quality of Life among type 1 and type 2 patients switching from MDI7
  • 90% of Omnipod® users prefer the Omnipod® over their previous diabetes management solution.8

*The Pod has an IP28 rating for up to 25 feet for 60 minutes. The PDM is not waterproof.
**Up to 72 hours of continuou+s insulin delivery.
***Insulin Choice: U-100 rapid-acting insulin used for both basal and bolus doses. Fiasp®, NovaLog®, Humalog®, Apidra®, Admelog®, and Lyumjev® cleared for use within the Pod.

How to process the script

DASH® 5-pack Pod NDC 08508-2000-05
Fill to patient insulin requirement:
2 boxes/month = 72 hour change out for 30 day supply
3 boxes/month = 48 hour change out for 30 day supply

Personal Diabetes Manager (PDM)
Supplied by Insulet, maker of Omnipod DASH®
Supplied FREE of charge with the first box of Pods.

Omnipod Logo

Want to learn more and subscribe to our news?

Visit omnipod.com/HCP/Omnipod DASH


Sincerely,
Omnipod® Team

References:

1.More than 69% of HCPs agree that Omnipod DASH® System simplifies diabetes care for patients living with diabetes. 140 HCPs were surveyed to gauge practical experience of Omnipod DASH® System use. Seagrove Partners, LLC. 2020.

2.More than 70% of HCPS agree that Omnipod DASH® System simplifies insulin delivery for people with Type 1 and Type 2 diabetes. 140 HCPs were surveyed to gauge the practical experiences of Omniopod DASH® System use. Seagrove Partners, LLC. 2020.

3. 14 injections/3 days based on individuals on MDI taking 3 bolus and 1-2 basal injections/day multiplied by 3 days. Chiang et al. 2014.

4. More than 64% of HCPs agree that Omnipod DASH® System simplifies getting started for people with Type 1 and Type 2 diabetes. 140 HCPs were surveyed to gauge the practical experiences of Omniopod DASH® System use. Seagrove Partners, LLC. 2020.

5. Exact coverage eligibility and restrictions vary by insurer and health plan. Exact retail pharmacy availability varies by geography.

6. More than 67% of HCPs agree that Omnipod DASH® System simplifies diabetes management for people with Type 1 and Type 2 diabetes. 140 HCPs were surveyed to gauge the practical experiences of Omniopod DASH® System use. Seagrove Partners, LLC. 2020.

7. Based on the HCPs survey conducted in November 2020 by Seagrove Partners, LLC. 2020. 140 HCPs were surveyed to gauge the practical experiences of Omniopod DASH® System use. More than 74% of HCPs agree that Omnipod DASH® System simplifies improves adherence among Type 1 and Type 2 patients. 83% of HCPs believe that Omnipod DASH® System improves QoL among Type 1 and Type 2 patients switching from MDI.

8. Orchard Hill - Customer Satisfaction Results - 5Jan2020, pg. 36.


If you do not want to receive future emails from us, please email us at HCPOptout@insulet.com with the words "Opt Out" in your message.


Omnipod Logo
Contact Us Private Policy FAQ


©2021 Insulet Corporation, Omnipod, the Omnipod logo, DASH, the DASH logo, All other trademarks are property of their respective owners. The use of third party trademarks does not contribute an endorsement or imply a relationshop or other affiliation.

INS-COS-10-2020-00017 V 1.0

Insulet Corporation
100 Nagog Park
Acion, MA 01720